As filed with
the U.S. Securities and Exchange Commission on July 30, 2020.
Registration No.
333-
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER THE
SECURITIES ACT OF 1933
COMPUGEN LTD.
|
(Exact name of registrant as specified in its charter)
|
|
Israel
|
|
N/A
|
(State or other
jurisdiction of
|
|
(I.R.S.
Employer
|
incorporation
or organization)
|
|
Identification
No.)
|
Azrieli
Center, 26 Harokmim Street, Building D
Holon,
5885849
(Address of
Principal Executive Offices)
|
|
Not
Applicable
(Zip
Code)
|
Compugen USA, Inc.
250 E.
Grand Ave, Suite 65
South
San Francisco CA, 90480
415-373-0556
(Name, address,
including zip code, and telephone number, including area code, of
agent for service)
Compugen Ltd. 2010 Share Incentive Plan
(Full title of the
plan)
Anat
Cohen-Dayag, Ph.D.
President and Chief Executive Officer
Compugen Ltd.
Azrieli
Center, 26 Harokmim Street, Building D
Holon,
5885849 Israel
Phone:
+972-3-765-8585
Fax:
+972-3-765-8555
(Name, address, including
Zip Code, and Telephone number, including area code, of agent for
service)
Copies
to:
|
Ari
Krashin
|
Daniel
I. Goldberg, Esq.
|
Eran
Ben Dor
|
Compugen Ltd.
|
Cooley
LLP
|
Compugen Ltd.
|
26
Harokmim Street
Building D
|
55
Hudson Yards
|
26
Harokmim Street
Building D
|
Holon,
5885849, Israel
|
New
York, NY 10001-2157
|
Holon,
5885849, Israel
|
Tel:
972-3-765-8585
|
Tel:
212-479-6000
|
Tel:
972-3-765-8585
|
Fax:
972-3-765-8555
|
Fax:
212 479 6275
|
Fax:
972-3-765-8555
|
|
|
|
Indicate by check mark whether the
registrant is a large accelerated filer, an accelerated filer, a
non-accelerated filer, a smaller reporting company or an emerging
growth company. See the definitions of “large accelerated filer,”
“accelerated filer,” “smaller reporting company” and “emerging
growth company” in Rule 12b-2 of the Exchange Act. (Check
one):
Large accelerated filer ☐
|
Accelerated
filer ☒
|
Non-accelerated filer ☐
|
Smaller reporting company ☐
|
Emerging growth company ☐
|
If an emerging growth company,
indicate by check mark if the registrant has elected not to use the
extended transition period for complying with any new or revised
financial accounting standards provided pursuant to Section
7(a)(2)(B) of the Securities Act. ☐
CALCULATION OF REGISTRATION FEE
Title of securities to be registered
|
|
Amount to
be
registered(1)
|
|
|
Proposed maximum
offering price per share
|
|
|
Proposed maximum
aggregate offering price
|
|
|
Amount of
registration
fee
|
|
Ordinary Shares,
nominal (par) value NIS 0.01 per share
|
|
|
|
(2)
|
|
$
|
14.23
|
(3)
|
|
$
|
71,125,000.00
|
(3)
|
|
$
|
9,232.03
|
|
(1) |
Pursuant to Rule 416 under the Securities Act of 1933, as
amended (the “Securities Act”), this registration statement shall
also cover any additional ordinary shares nominal (par) value NIS
0.01 per share (the “Ordinary Shares”) that may become issuable by
reason of any stock dividend, stock split, recapitalization or
other similar transaction effected without receipt of consideration
that increases the number of outstanding Ordinary Shares of the
registrant.
|
(2) |
Represents an additional 5,000,000 Ordinary Shares issuable
under the Compugen Ltd. 2010 Share Incentive Plan, as amended (the
“2010 Plan”), over and above the number of Ordinary Shares issuable
under the 2010 Plan that were previously registered under the
Securities Act.
|
(3) |
Pursuant to Rule 457(h)(1) under the Securities Act, the
proposed maximum offering price per security and the proposed
maximum aggregate offering price are based on the average of the
high and low sale prices per share of the registrant’s Ordinary
Shares as reported by The Nasdaq Global Market on July 24,
2020.
|
EXPLANATORY NOTE
This
Registration Statement relates to an increase of an additional
5,000,000 Ordinary Shares of Compugen Ltd. (the “Registrant”) that
are being issued and sold, or may be issued and sold, upon exercise
of options or other awards granted by the Registrant to
participants in the 2010 Plan, where an increase of 2,000,000
Ordinary Shares was approved by the Board of Directors on May 5,
2020 and additional increase of 3,000,000 Ordinary Shares was
previously approved by the Board of Directors.
Reference is
made to the Registrant’s Registration Statements on Form S-8 filed
with the Securities and Exchange Commission (the “Commission”) on
September 7, 2010 (Registration No. 333-169239), June 11, 2015
(Registration No. 333-204869) and March 27, 2018 (Registration No.
333- 223937) (together, the “Prior Registration Statements”),
pursuant to which a total of 13,345,436 Ordinary Shares
issuable under the 2010 Plan were registered under the Securities
Act. Pursuant to General Instruction E to Form S-8, the
contents of the Prior Registration Statements are hereby
incorporated by reference in their entirety, except as otherwise
updated or modified by this Registration Statement.
PART
II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
ITEM 3.
INCORPORATION OF DOCUMENTS BY REFERENCE.
The following
documents filed by the Registrant with the Commission pursuant to
the Securities Exchange Act of 1934, as amended (the “Exchange
Act”) are hereby incorporated herein by reference and made a part
hereof:
|
(i) |
The Registrant’s Annual Report on Form 20-F for the fiscal
year ended December 31, 2019, filed with the Commission on February
24, 2020, as amended on February 27, 2020 (File No.
000-30902);
|
|
(ii) |
The Registrant’s Reports of Foreign Private Issuer on Form
6-K, as filed with the Commission on January 9, 2020, February 20,
2020, March 9, 2020, March 11, 2020, March 12, 2020, March 13,
2020, March 17, 2020, April 6, 2020, April 15, 2020, April 27,
2020, May 6, 2020, May 27, 2020, June 1, 2020 and July 30, 2020
(File No. 000-30902); and
|
|
(iii) |
The description of the Registrant’s Ordinary Shares in the
Registrant’s Registration Statement on Form 8-A (File
No. 000-30902) filed with the Commission under the Securities
Exchange Act of 1934, as amended (the “Exchange Act”), on August 2,
2000, including any amendment or report filed for the purpose of
updating such description.
|
All documents
subsequently filed by the Registrant with the Commission pursuant
to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act, after
the date of this Registration Statement and prior to the filing of
a post-effective amendment which indicates that all securities
offered have been sold or which deregisters all securities then
remaining unsold, and all Reports of Foreign Private Issuer on Form
6-K submitted by the Registrant to the Commission during such
period, or portions thereof that are identified in such forms as
being incorporated into this Registration Statement, shall be
deemed to be incorporated by reference in this Registration
Statement and to be a part hereof from the date of filing such
documents. Any document, or any statement contained in a document,
incorporated or deemed to be incorporated by reference herein shall
be deemed to be modified or superseded for purposes of this
Registration Statement to the extent that a document or statement
contained herein, or in any other subsequently filed document that
also is deemed to be incorporated by reference herein, modifies or
supersedes such document or statement. Any statement so modified or
superseded shall not be deemed, except as so modified or
superseded, to constitute a part of this Registration Statement.
Subject to the foregoing, all information appearing in this
Registration Statement is qualified in its entirety by the
information appearing in the documents incorporated by
reference.
ITEM 8.
EXHIBITS.
The following is
a list of exhibits filed as a part of this Registration Statement
which are incorporated herein:
The Registrant. Pursuant to the
requirements of the Securities Act of 1933, the Registrant
certifies that it has reasonable grounds to believe that it meets
all of the requirements for filing on Form S-8 and has duly caused
this Registration Statement to be signed on its behalf by the
undersigned, thereunto duly authorized, in City of Holon, State of
Israel, on July 30, 2020.
|
Compugen Ltd.
By: /s/ Anat Cohen-Dayag, Ph.D.
Anat Cohen-Dayag, Ph.D.
Chief Executive Officer and President
|
Each person
whose signature appears below constitutes and appoints Anat
Cohen-Dayag, Ph.D., Ari Krashin and Eran Ben Dor, and each of them
singly, his true and lawful attorneys-in-fact and agents, with full
power of substitution and resubstitution in each of them singly,
for him and in his name, place and stead, and in any and all
capacities, to sign any and all amendments (including
post-effective amendments) to this Registration Statement of
Compugen Ltd. and to file the same, with all exhibits thereto and
other documents in connection therewith, with the Securities and
Exchange Commission, granting to the attorneys-in-fact and agents,
and each of them, full power and authority to do and perform each
and every act and thing requisite or necessary to be done in or
about the premises, as full to all intents and purposes as he might
or could do in person, hereby ratifying and confirming all that the
attorneys-in-fact and agents or any or each of them or their
substitute may lawfully do or cause to be done by virtue
hereof.
Pursuant to the
requirements of the Securities Act of 1933, this Registration
Statement has been signed by the following persons in the
capacities and on the dates indicated.
Signature
|
Title(s)
|
Date
|
/s/ Anat Cohen-Dayag, Ph.D.
Anat Cohen-Dayag, Ph.D.
|
Chief Executive Officer and President and Director
(principal executive officer)
|
July 30, 2020
|
/s/ Ari Krashin
Mr.
Ari Krashin
|
Chief Financial Officer
(principal financial and accounting officer)
|
July 30, 2020
|
/s/ Paul Sekhri
Mr. Paul
Sekhri
|
Chairman of the Board
|
July 30, 2020
|
/s/ Sandy Zweifach
Mr. Sandy
Zweifach
|
Director
|
July 30, 2020
|
/s/ Dr. Jean-Pierre Bizzari
Dr.
Jean-Pierre Bizzari
|
Director
|
July 30, 2020
|
/s/ Eran Perry
Mr. Eran
Perry
|
Director
|
July 30, 2020
|
/s/
Gilead Halevy
Mr.
Gilead Halevy
|
Director
|
July 30, 2020
|
/s/ Dr. Kinneret Livnat Savitzky
Dr.
Kinneret Livnat Savitzky
|
Director
|
July 30, 2020
|
Compugen USA, Inc.
By:
/s/ Julia Decker
Name: Julia Decker
Title: Treasurer and Director of Finance of Compugen USA,
Inc.
|
Authorized U.S. Representative
|
July 30, 2020
|